Screening for inducers of apoptosis in apoptosis-resistant human carcinoma cells

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 145-156

  Umezawa, Kazuo ^a   Nakazawa, Kumi ^a   Uchihata, Yuki ^a   Otsuka, Masami ^b  

^a KEIO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BE 14106; BETA LACTAM ANTIBIOTIC; BLEOMYCIN; BLEOMYCIN A2; BLEOMYCIN DERIVATIVE; CYCLOPEPTIDE; DRUG DERIVATIVE; GLYCOPEPTIDE; HISTIDINE; HISTIDINE-PYRIDINE-HISTIDINE-3; HPH 3; MACROLIDE; POLYOXYPEPTIN A; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CARCINOMA CELL; CELL CULTURE; CHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG RESISTANCE; DRUG SCREENING; HUMAN; HUMAN CELL; IRON CHELATION; PANCREAS ADENOCARCINOMA; PANCREAS TUMOR; PATHOLOGY; STREPTOMYCES;

EID: 0032879494     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00022-3     Document Type: Conference Paper

References (22)

1. N. ITOH, S. YONEHARA, A. ISHII, M. YONEMARA, S.-I. MIZUSHIMA, M. SAMESHIMA, A. HASE, Y. SETO and S. NAGATA, The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis, Cell 66, 223-243 (1991).
2. S. M. LASTER, J. G. WOOD and L. R. GOODING, Tumor necrosis factor can induce both apoptotic and necrotic forms of cell lysis, J. Immunol. 141, 2629-2634 (1988).
3. P. MARTIKAINEN, N. KYPRIANOU and J. T. ISAACS, Effect of transforming growth factor-β1 on proliferation and death of rat prostatic cells, Endocrinology 127, 2963-2968 (1990).
4. S. SIMIZU, M. IMOTO and K. UMEZAWA, Induction of apoptosis by erbstatin in mouse leukemia L1210 cells, Biosci. Biotechnol. Biochem. 58, 1549-1552 (1994).
5. N. MEYDAN, T. GRUNBERGER, H. DADI, M. SHAHAR, E. ARPAIA, Z. LAPIDOT, J. S. LEEDER, M. FREEDMAN, A. COHEN, A. GAZIT, A. LEVITZKI and C. M. ROIFMAN, Inhibition of acute lymphoblastic leukemia by a Jak-2 inhibitor, Nature 379, 645-648 (1996).
6. I. FATH, F. SCHWEIGHOFFER, I. REY, M.-C. MULTON, J. BOIZIAN, M. DUCHESNE and B. TOCQUE, Cloning of Grb2 isoform with apoptotic properties, Science 264, 971-974 (1994).
7. P. R. WALKER, C. SMITH, T. YOUDALE, J. LEBLANC, J. F. WHITFIELD and M. SIKORSKA, Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes, Cancer Res. 51, 1078-1085 (1991).
8. Y.-H. LING, W. PRIEBE and R. PEREZ-SOLER, Apoptosis induced by anthracycline antibiotics in P338 parent and multidrug-resistant cells, Cancer Res. 53, 1845-1852 (1993).
9. M. G. ORMEROD, C. F. O'NEILL, D. ROBERTSON and K. R. HARRAP, Cisplatin induces apoptosis in a human ovarian carcinoma cell line without concomitant internucleosomal degradation of DNA, Exptl. Cell Res. 211, 231-237 (1994).
10. W. H. CHEN, J. S. HOROSZEWICZ, S. S. LEONG, T. SHIMANO, R. PENERANTE, W. H. SANDERS, R. BERJIAN, H. O. DOUGLASS, E. W. MARTIN and T. M. CHU, Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites, In Vitro 18, 24-34 (1982).
11. M. OTUSKA, H. SATAKE and Y. SUGIURA, Restructuring of the bleomycin metal core. Novel oxygen-activating ligands with symmetrized structure, Tetrahedron Letters 34, 8497-8500 (1993).
12. K. UMEZAWA, K. NAKAZAWA, T. UEMURA, Y. IKEDA, S. KONDO, H. NAGANAWA, N. KINOSHITA, H. HASHIZUME, M. HAMADA, T. TAKEUCHI and S. OHBA, Polyoxypeptin isolated from Streptomyces: a bioactive cyclic depsipeptide containing the novel amino acid 3-hydroxy-3-methylproline, Tetrahedron Letters 39, 1389-1392 (1998).
13. K. KOJIRI, S. NAKAJIMA, H. SUZUKI, H. KONDO and H. SUDA, A new macrocyclic lactam antibiotic, BE14106 I. Taxonomy, isolation, biological activitiy and structural elucidation, J. Antibot. 45, 868-874 (1991).
14. H. UMEZAWA, T. TAKITA, Y. SUGIURA, M. OTSUKA, S. KOBAYASHI and M. OHNO, DNA-bleomycin interaction. Nucleotide sequence-specific binding and cleavage of DNA by bleomycin, Tetrahedron 40, 501-509 (1984).
15. T. HENNET, C. RICHTER and E. PETERHANS, Tumour necrosis factor-α induces superoxide anion generation in mitochondria of L929 cells, Biochem. J. 289, 587-592 (1993).
16. C. LAFON, C. MATHIEU, M. GUERRIN, O. PIERRE, S. VIDAL and A. VALETTE, Transforming growth factor β-1 induced apoptosis in human ovarian carcinoma cells: protection by the antioxidant N-acetylcysteine and bcl-2, Cell Growth Differ. 7, 1095-1104 (1996).
17. S. SIMIZU, M. TAKADA, K. UMEZAWA and M. IMOTO, Requirement of caspase-3 (-like) protease-mediated hydrogen peroxide production for apoptosis induced by anticancer drugs, J. Biol. Chem. 273, 26900-26907 (1998).
18. R. SUGINAKA, R. IZUI, J. INOUE, Y. MURAOKA, K. YAMAGUCHI, M. OTSUKA and K. UMEZAWA, Induction of apoptosis in human pancreatic carcinoma cells by a synthetic bleomycin-like ligand, Jap. J. Cancer Res. 89, 947-953 (1998).
19. E. A. SAUSVILLE, J. PEISACH and S. B. HORWITZ, A role for ferrous ion and oxygen in the degradation of DNA by bleomycin, Biochem. Biophys. Res. Commun. 73, 814-822 (1976).
20. D. H. PETERING, R. W. BYRNES and W. E. ANTHOLINE, The role of redox-active metals in the mechanism of action of bleomycin, Chem. Biol. Interact. 73, 133-182 (1990).
21. R. S. BODANNES and P. C. CHAN, Ascorbic acid as a scavenger of singlet oxygen, FEBS Letters 15, 195-196 (1979).
22. O. TOUNEKTI, G. PRON, J. BELEHRADEK JR. and L. M. MIR, Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized, Cancer Res. 53, 5462-5469 (1993).